FDA Device Intelligence
Home › RANDOX LABORATORIES LIMITED › SEROLOGY ToRCH NEGATIVE CONTROL (ToRCH CONTROL -)

SEROLOGY ToRCH NEGATIVE CONTROL (ToRCH CONTROL -)

RANDOX LABORATORIES LIMITED · Model SR10347 · UDI-DI 05055273216400

OHQ Prescription
0
510(k) clearances
6
Adverse events
27
Recalls
57
Facilities

Description

ToRCH Negative Control is intended for use as an unassayed non-reactive quality assurance reagent with in vitro assays detecting IgG and IgM antibodies to Cytomegalovirus (CMV), IgG and IgM antibodies to Rubella virus, IgG and IgM antibodies to Toxoplasma gondii, IgG and IgM antibodies to Herpes Simplex Type 1 and 2, IgG antibodies to Mumps Virus, IgG antibodies to Rubeola Virus (Measles), IgG antibodies to Varicella Zoster Virus, IgG antibodies to Helicobacter pylori, IgG antibodies to Treponema pallidum (Syphilis), IgG and IgM antibodies to the Viral Capsid Antigen of Epstein-Barr virus (EBV VCA) and IgG antibodies to the Viral Polypeptide Nuclear Antigen of Epstein-Barr Virus (EBV EBNA IgG).

Recalls

DateFirmReason
2026-08-14TECHNO-PATH MANUFACTURING LTD.A routine stability studies have identified a stability drift affecting the Ammonia (NH4+) analyte in specific lots of Multichem AE quality control material. Additional testing con
2026-08-14TECHNO-PATH MANUFACTURING LTD.A routine stability studies have identified a stability drift affecting the Ammonia (NH4+) analyte in specific lots of Multichem AE quality control material. Additional testing con
2026-08-14TECHNO-PATH MANUFACTURING LTD.A routine stability studies have identified a stability drift affecting the Ammonia (NH4+) analyte in specific lots of Multichem AE quality control material. Additional testing con
2025-10-17TECHNO-PATH MANUFACTURING LTD.Potential of negative recovery of the HBsAg analyte across two (2) lots of Multichem ID-B Positive Control when tested on the Alinity i platform.
2025-10-17TECHNO-PATH MANUFACTURING LTD.Potential of negative recovery of the HBsAg analyte across two (2) lots of Multichem ID-B Positive Control when tested on the Alinity i platform.
2025-02-20Microbiologics IncThe RSV target may give a late Ct value and could potentially not pass QC.
2025-02-20Microbiologics IncThe A549 human cell target (human cells for sample adequacy control) may give a late Ct value.
2025-01-20Microbiologics IncInternal quality control procedures were not followed correctly for the testing/release of three lots of 8234/8235. This resulted in the release of products that should have failed
2025-01-20Microbiologics IncInternal quality control procedures were not followed correctly for the testing/release of three lots of 8234/8235. This resulted in the release of products that should have failed
2024-01-08Microbiologics IncThe negative control was contaminated with one of the positive control pathogens (Norovirus). This would result in users getting a positive call for Norovirus when running the neg

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.